KOL Identification

A leading diagnostics player wanted an assessment of the current and future carrier screening landscape, primarily in the U.S., to guide their product development strategy

A research tools start-up enlisted DeciBio to support their go-to-market strategy and activities for their novel sequencing technology by conducting pricing voice-of-customer research and evaluating potential pricing strategies

A multinational pharmaceutical and diagnostics company was interested in learning more about the U.S. market opportunity for their novel noninvasive prenatal test in development

DeciBio conducted financial projections, valuation, and assisted with messaging to aid client's public listing to NASDAQ

A diagnostics player wanted to determine with indications / use cases to target and develop a product road map

A diagnostic company wanted to assess the current and expected future landscapes for biopharma oncology genomics research and Dx / CDx